The abstract is read at the publisher; the summary is JClub's.
Higher prerandomization heart rate in stable post–myocardial infarction patients with left ventricular ejection fraction ≥40% is linked to adverse cardiovascular events and mortality.
- Why it matters: Heart rate is prognostic after MI, but whether this holds in the modern reperfusion era—and how it relates to β-blocker interruption—was uncertain.
- What they did: In a prespecified secondary analysis of the ABYSS trial, 3698 stable post-MI patients were randomized to continue or interrupt β-blockers and stratified into prerandomization HR tertiles.
- The result: Interrupting β-blockers substantially increased heart rate and was consistently linked with worse cardiovascular outcomes and mortality across baseline HR tertiles.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.